Intellia therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Intellia therapeutics Contact Number

Patients and Medical Affairs Contact. Clinical trial A test of a new medical treatment or procedure in human volunteers with the purpose of evaluating a medical, surgical or behavioral intervention. Clinical trials typically follow preclinical (non-human) studies and are the primary way that clinical researchers and regulatory agencies evaluate whether a new treatment is safe and effective in

Contact US: https://www.intelliatx.com/contact/

What does intellia therapeutics mean?

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene-editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron.

Where is intellia therapy headquarters?

Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.

How much money has intellia therapeutics raised?

Intellia Therapeutics has raised a total of $85M in funding over 2 rounds. Their latest funding was raised on Sep 1, 2015 from a Series B round. Which funding types raised the most money? Show How much funding has this organization raised over time? Show Seven veteran product leaders share their best advice on how to overcome product challenges.

Who are intellias competitors?

Intellia formed a division called eXtellia Therapeutics to manage the CAR-T collaboration with Novartis. As of February 2015, Intellia's competitors included CRISPR Therapeutics (with IP invented by Emmanuelle Charpentier ), Editas Medicine (with IP invented by Feng Zhang from the Broad Institute) and Horizon Discovery.

Modular

29 People Used

See More ››

Home

Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic. Our company’s unique strengths include our modular lipid nanoparticle delivery system and our determined focus on …

View Contact ››

Vivo)

54 People Used

See More ››

Who to contact

Genome editing uses systems to make the DNA change inside the cell. These cells can be edited in the body (in vivo) or outside the body (ex vivo) from a patient or donor. science might advance your programs, or if your technology could advance the science, please contact us.

View Contact ››

Phone

65 People Used

See More ››

Intellia Therapeutics

Phone Number (857) 285-6200 Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases.

View Contact ››

Intellia

67 People Used

See More ››

Intellia Therapeutics

Intellia Therapeutics’s headquarters are in 40 Erie St, Ste 130, Cambridge, Massachusetts, 02139, United States What is Intellia Therapeutics’s phone number? Intellia Therapeutics’s phone number

View Contact ››

Intellia’s

66 People Used

See More ››

Investor FAQs Intellia Therapeutics

Intellia’s headquarters are located at 40 Erie Street, Suite 130 Cambridge, Massachusetts 02139 U.S. The main office phone number is (857) 285-6200. On which exchange is Intellia listed, what is its ticker symbol, and when did it go public? What is Intellia’s CUSIP number?

View Contact ››

Intellia

49 People Used

See More ››

Intellia Therapeutics Company Profile

Intellia Therapeutics has 270 employees at their 1 location and $57.99 M in annual revenue in FY 2020. See insights on Intellia Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

View Contact ››

Intellia

85 People Used

See More ››

Intellia Therapeutics, Inc. LinkedIn

Intellia Therapeutics, Inc.

View Contact ››

Page

40 People Used

See More ››

Contact Intellia Ltd

If you have a question about any of our products and solutions, please contact Intellia using the enquiry form on this page. You can also find the contact information for our two offices in the footer area at the bottom of this page.

View Contact ››

Intellia

61 People Used

See More ››

Intellia Therapeutics

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene-editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron. History. Intellia Therapeutics was founded in May 2014 to develop

View Contact ››

Please leave your comments here:

Popular Brands

Itc
Icbc
Igt
Incyte
Ibm
Intel
Intuit
Iac
Insmed
Iff
Iqvia
Ing
Ipg